Results: From 2010 to 2040, we have researched 45 patients of primary cerebral lymphoma, treated by high - dose Methotrexate with and without Rituximab regimen (six cycles of treatment), with following result: The rate of complete response to Methotrexate alone and combined with Rituximab was 71.4% and 58.8% respectly.